370 related articles for article (PubMed ID: 18931991)
1. [Testosterone substitution with special regard to prostate cancer].
Beintker M; Behre H
Urologe A; 2008 Dec; 47(12):1588-91. PubMed ID: 18931991
[TBL] [Abstract][Full Text] [Related]
2. [Testosterone and the prostate].
Sperling H; Rossi R; Lümmen G; Rübben H
Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
[TBL] [Abstract][Full Text] [Related]
3. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
4. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
Rhoden EL; Morgentaler A
J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.
Catarinicchia SP; Crawford ED
Nat Rev Urol; 2016 Sep; 13(9):497-8. PubMed ID: 27431338
[No Abstract] [Full Text] [Related]
6. Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
Heaton JP
Can J Urol; 2002 Dec; 9(6):1677-80. PubMed ID: 12517308
[TBL] [Abstract][Full Text] [Related]
7. [Testosterone substitution in aging males. Which questions are answered?].
Krause W
Urologe A; 2004 Sep; 43(9):1097-100. PubMed ID: 15368046
[TBL] [Abstract][Full Text] [Related]
8. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
Gould DC; Kirby RS
Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
[TBL] [Abstract][Full Text] [Related]
9. Testosterone deficiency.
Traish AM; Miner MM; Morgentaler A; Zitzmann M
Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
[TBL] [Abstract][Full Text] [Related]
10. [Testosterone substitution therapy in prostate cancer].
Kaminsky A; Sperling H
Urologe A; 2011 Aug; 50(8):977-84. PubMed ID: 21811932
[TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement therapy and prostate cancer: a word of caution.
Brand TC; Canby-Hagino E; Thompson IM
Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
13. [Testosterone substitution in patients with hypogonadism].
Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
[TBL] [Abstract][Full Text] [Related]
14. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
Traish A
Investig Clin Urol; 2016 Nov; 57(6):384-400. PubMed ID: 27847912
[TBL] [Abstract][Full Text] [Related]
15. [Andropause].
Hochreiter WW; Ackermann DK; Brütsch HP
Ther Umsch; 2005 Dec; 62(12):821-6. PubMed ID: 16405287
[TBL] [Abstract][Full Text] [Related]
16. Andropause (androgen deficiency of the aging male): diagnosis and management.
Staerman F; Léon P
Minerva Med; 2012 Oct; 103(5):333-42. PubMed ID: 23042368
[TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.
Leibowitz RL; Dorff TB; Tucker S; Symanowski J; Vogelzang NJ
BJU Int; 2010 May; 105(10):1397-401. PubMed ID: 19912179
[TBL] [Abstract][Full Text] [Related]
18. Andropause: is androgen replacement therapy indicated for the aging male?
Hijazi RA; Cunningham GR
Annu Rev Med; 2005; 56():117-37. PubMed ID: 15660505
[TBL] [Abstract][Full Text] [Related]
19. [When is testosterone substitution a medically necessary treatment?].
Hakimi R
Versicherungsmedizin; 2012 Jun; 64(2):74-7. PubMed ID: 22808644
[TBL] [Abstract][Full Text] [Related]
20. Testosterone and prostate cancer: what are the risks for middle-aged men?
Morgentaler A
Urol Clin North Am; 2011 May; 38(2):119-24. PubMed ID: 21621078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
